HomeDTC • FRA
add
Defence Therapeutics Inc
Previous close
€0.46
Day range
€0.46 - €0.46
Year range
€0.32 - €1.17
Market cap
44.72M CAD
Avg Volume
6.55K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 599.46K | 24.08% |
Net income | -703.00K | -15.84% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -589.88K | -26.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.32M | 1,669.07% |
Total assets | 2.77M | 551.91% |
Total liabilities | 4.18M | -8.13% |
Total equity | -1.41M | — |
Shares outstanding | 54.73M | — |
Price to book | -15.20 | — |
Return on assets | -67.81% | — |
Return on capital | -165.43% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -703.00K | -15.84% |
Cash from operations | -720.66K | -924.48% |
Cash from investing | -21.11K | — |
Cash from financing | 1.82M | 14,405.67% |
Net change in cash | 1.09M | 1,358.19% |
Free cash flow | -494.60K | -349.58% |
About
Founded
2017
Headquarters
Website
